These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 26399531)

  • 21. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
    Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.
    Finnin MS; Donigian JR; Cohen A; Richon VM; Rifkind RA; Marks PA; Breslow R; Pavletich NP
    Nature; 1999 Sep; 401(6749):188-93. PubMed ID: 10490031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells.
    Di Bernardo G; Alessio N; Dell'Aversana C; Casale F; Teti D; Cipollaro M; Altucci L; Galderisi U
    J Cell Physiol; 2010 Nov; 225(2):537-44. PubMed ID: 20458754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function.
    Wang P; Zhang P; Huang J; Li M; Chen X
    Neurotoxicology; 2013 Jul; 37():51-62. PubMed ID: 23558232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition.
    Xie L; Santhoshkumar P; Reneker LW; Sharma KK
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4731-40. PubMed ID: 24994865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibition impairs normal intestinal cell proliferation and promotes specific gene expression.
    Roostaee A; Guezguez A; Beauséjour M; Simoneau A; Vachon PH; Levy E; Beaulieu JF
    J Cell Biochem; 2015 Nov; 116(11):2695-708. PubMed ID: 26129821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibitors repress chondrosarcoma cell proliferation.
    Zhu J; Gu J; Ma J; Xu Z; Tao H
    J BUON; 2015; 20(1):269-74. PubMed ID: 25778327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review).
    Emanuele S; Lauricella M; Tesoriere G
    Int J Oncol; 2008 Oct; 33(4):637-46. PubMed ID: 18813776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of T cell functions by hydroxamic acid-based histone deacetylase inhibitors.
    Kim YH; Lee JK
    Arch Pharm Res; 2012 May; 35(5):929-36. PubMed ID: 22644861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity.
    Li X; Hou J; Li X; Jiang Y; Liu X; Mu W; Jin Y; Zhang Y; Xu W
    Eur J Med Chem; 2015 Jan; 89():628-37. PubMed ID: 25462271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trichostatin A induces mesenchymal-like morphological change and gene expression but inhibits migration and colony formation in human cancer cells.
    Han RF; Li K; Yang ZS; Chen ZG; Yang WC
    Mol Med Rep; 2014 Dec; 10(6):3211-6. PubMed ID: 25269990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.
    Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q
    J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism.
    Chittur SV; Sangster-Guity N; McCormick PJ
    BMC Genomics; 2008 Oct; 9():507. PubMed ID: 18959802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents.
    Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin.
    Uchida H; Maruyama T; Nagashima T; Asada H; Yoshimura Y
    Endocrinology; 2005 Dec; 146(12):5365-73. PubMed ID: 16123169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of Pulmonary Fibrosis via Trichostatin A (TSA) in Bleomycin Induced Rats.
    Ye Q; Li Y; Jiang H; Xiong J; Xu J; Qin H; Liu B
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):219-26. PubMed ID: 25363222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation.
    Chen W; Chen L; Zhang Z; Meng F; Huang G; Sheng P; Zhang Z; Liao W
    Biochim Biophys Acta; 2016 Dec; 1863(12):2881-2891. PubMed ID: 27638301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of histone deacetylase on prostate carcinoma.
    Zhang Y; Xu Q; Liu G; Huang H; Lin W; Huang Y; Chi Z; Chen S; Lan K; Lin J; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(11):15030-4. PubMed ID: 26823840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, Biological Evaluation, and Computer-Aided Drug Designing of New Derivatives of Hyperactive Suberoylanilide Hydroxamic Acid Histone Deacetylase Inhibitors.
    Zhang S; Huang W; Li X; Yang Z; Feng B
    Chem Biol Drug Des; 2015 Oct; 86(4):795-804. PubMed ID: 25763653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.